Left Atrial Thrombus in Patients With Non-valvular Atrial Fibrillation: A Cross-Sectional Study in China

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 May 19

PMID 35586655

Authors

Shaobo Shi

Qingyan Zhao

Tao Liu

Shujuan Zhang

Jinjun Liang

Yanhong Tang

Bo Yang

He Huang

Congxin Huang

Affiliations

Soon will be listed here.

Abstract

Background: Stroke is predominately attributed to left atrial thrombus (LAT) in patients with non-valvular atrial fibrillation (NVAF), however, its detection rate in real clinical practice has been few reported in China.

Objective: This study aimed to investigate the prevalence and associated factors of LAT in patients with NVAF in China.

Methods: All adult NVAF patients undergoing transesophageal echocardiography (TEE) in the China Atrial Fibrillation Center database from January 2017 to January 2022 were enrolled in this study. The prevalence of LAT was calculated, and associated factors were identified.

Results: A total of 36,007 NVAF inpatients from 602 hospitals in 30 provinces/autonomous regions/municipalities were included in the final analysis, with a median age of 66 years and 39.4% were female. LAT was present in 1,467 (4.1%) patients overall, 2.7, 5.7, and 6.8% in patients with paroxysmal, persistent, and long-standing persistent AF, respectively. In subgroup analysis, including age ≥ 65 years, CHADS-VAS score ≥ 2, left atrial diameter (LAD) ≥ 50 mm, left ventricular ejection fraction (LVEF) < 50%, and anticoagulation, patients with paroxysmal AF always had the lowest LAT prevalence, followed by patients with persistent and long-standing persistent AF. Patients treated with anticoagulants had less prevalent LAT than those without anticoagulation (2.1 vs. 5.0%, p < 0.001). In multivariate analysis, AF pattern (both persistent AF and long-standing persistent AF), hypertension, chronic heart failure, coronary heart disease, transient ischemic attack/stroke, diabetes mellitus, and LAD (per 5 mm) were associated with an increased prevalence of LAT. However, LVEF (per 5%) and anticoagulation were associated with a reduced prevalence of LAT.

Conclusion: LAT was found in 4.1% of Chinese adult NVAF inpatients underwent TEE in real-world experience. The prevalence of LAT mainly associated with non-paroxysmal AF, cardiovascular diseases, diabetes mellitus, enlarged left atrium, lower LVEF, and lack of anticoagulation therapy.

Citing Articles

Development and validation of an interpretable machine learning model for predicting left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients.

Huang C, Shu S, Zhou M, Sun Z, Li S PLoS One. 2025; 20(1):e0313562.

PMID: 39820175 PMC: 11737704. DOI: 10.1371/journal.pone.0313562.

Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study.

Cui J, Zhang Y, Wang Y, Liu F, Lai H, Ji Q BMC Cardiovasc Disord. 2025; 25(1):19.

PMID: 39806292 PMC: 11726944. DOI: 10.1186/s12872-025-04473-6.

Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation.

Cui J, Xia S, Tang R, He L, Guo X, Li S BMC Cardiovasc Disord. 2024; 24(1):398.

PMID: 39085776 PMC: 11290267. DOI: 10.1186/s12872-024-04073-w.

Predictive value of nutritional indices for left atrial thrombus in patients with valvular atrial fibrillation.

Zhou Y, Liang E, Ma J, Wang X, Fu H BMC Cardiovasc Disord. 2023; 23(1):526.

PMID: 37891483 PMC: 10612230. DOI: 10.1186/s12872-023-03493-4.

Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry.

Pieszko K, Hiczkiewicz J, Lojewska K, Uzieblo-Zyczkowska B, Krzesinski P, Gawalko M Eur Heart J. 2023; 45(1):32-41.

PMID: 37453044 PMC: 10757867. DOI: 10.1093/eurheartj/ehad431.

References

Scherr D, Dalal D, Chilukuri K, Dong J, Spragg D, Henrikson C . Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008; 20(4):379-84. DOI: 10.1111/j.1540-8167.2008.01336.x. View

Bertaglia E, Anselmino M, Zorzi A, Russo V, Toso E, Peruzza F . NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world. Int J Cardiol. 2017; 249:179-183. DOI: 10.1016/j.ijcard.2017.07.048. View

Salmasi S, De Vera M, Safari A, Lynd L, Koehoorn M, Barry A . Longitudinal Oral Anticoagulant Adherence Trajectories in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2021; 78(24):2395-2404. DOI: 10.1016/j.jacc.2021.09.1370. View

Aimo A, Kollia E, Ntritsos G, Barison A, Masci P, Figliozzi S . Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis. Clin Res Cardiol. 2020; 110(11):1697-1703. DOI: 10.1007/s00392-020-01741-7. View

Shi S, Tang Y, Zhao Q, Yan H, Yu B, Zheng Q . Prevalence and risk of atrial fibrillation in China: A national cross-sectional epidemiological study. Lancet Reg Health West Pac. 2022; 23:100439. PMC: 9252928. DOI: 10.1016/j.lanwpc.2022.100439. View

Doukky R, Garcia-Sayan E, Patel M, Pant R, Wassouf M, Shah S . Impact of Diastolic Function Parameters on the Risk for Left Atrial Appendage Thrombus in Patients with Nonvalvular Atrial Fibrillation: A Prospective Study. J Am Soc Echocardiogr. 2016; 29(6):545-53. DOI: 10.1016/j.echo.2016.01.014. View

Ayirala S, Kumar S, OSullivan D, Silverman D . Echocardiographic predictors of left atrial appendage thrombus formation. J Am Soc Echocardiogr. 2011; 24(5):499-505. DOI: 10.1016/j.echo.2011.02.010. View

Romero J, Cao J, Garcia M, Taub C . Cardiac imaging for assessment of left atrial appendage stasis and thrombosis. Nat Rev Cardiol. 2014; 11(8):470-80. DOI: 10.1038/nrcardio.2014.77. View

Chung M, Refaat M, Shen W, Kutyifa V, Cha Y, Di Biase L . Atrial Fibrillation: JACC Council Perspectives. J Am Coll Cardiol. 2020; 75(14):1689-1713. DOI: 10.1016/j.jacc.2020.02.025. View

10.

Kaplon-Cieslicka A, Budnik M, Gawalko M, Peller M, Gorczyca I, Michalska A . Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus. Heart. 2019; 105(17):1310-1315. DOI: 10.1136/heartjnl-2018-314492. View

11.

Zhan Y, Joza J, Al Rawahi M, Barbosa R, Samuel M, Bernier M . Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation. Can J Cardiol. 2018; 34(3):252-261. DOI: 10.1016/j.cjca.2017.12.008. View

12.

Jame S, Barnes G . Stroke and thromboembolism prevention in atrial fibrillation. Heart. 2019; 106(1):10-17. PMC: 7881355. DOI: 10.1136/heartjnl-2019-314898. View

13.

Kitkungvan D, Nabi F, Ghosn M, Dave A, Quinones M, Zoghbi W . Detection of LA and LAA Thrombus by CMR in Patients Referred for Pulmonary Vein Isolation. JACC Cardiovasc Imaging. 2016; 9(7):809-818. DOI: 10.1016/j.jcmg.2015.11.029. View

14.

Lurie A, Wang J, Hinnegan K, McIntyre W, Belley-Cote E, Amit G . Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation. J Am Coll Cardiol. 2021; 77(23):2875-2886. DOI: 10.1016/j.jacc.2021.04.036. View

15.

Zhao Q, Shi S, Huang H, Jiang H, Yang B, Wu G . Contemporary characteristics, management, and outcomes of patients hospitalized for atrial fibrillation in China: results from the real-world study of Chinese atrial fibrillation registry. Chin Med J (Engl). 2020; 133(23):2883-2884. PMC: 10631585. DOI: 10.1097/CM9.0000000000001151. View

16.

Lowe B, Kusunose K, Motoki H, Varr B, Shrestha K, Whitman C . Prognostic significance of left atrial appendage "sludge" in patients with atrial fibrillation: a new transesophageal echocardiographic thromboembolic risk factor. J Am Soc Echocardiogr. 2014; 27(11):1176-83. DOI: 10.1016/j.echo.2014.08.016. View

17.

Perreault S, de Denus S, White-Guay B, Cote R, Schnitzer M, Dube M . Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation. Pharmacotherapy. 2019; 40(1):40-54. DOI: 10.1002/phar.2350. View

18.

Akoum N, Fernandez G, Wilson B, McGann C, Kholmovski E, Marrouche N . Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2013; 24(10):1104-9. PMC: 3818287. DOI: 10.1111/jce.12199. View

19.

Wei Y, Xu J, Wu H, Zhou G, Chen S, Wang C . Survey of Antithrombotic Treatment in Rural Patients (>60 years) with Atrial Fibrillation in East China. Sci Rep. 2018; 8(1):6830. PMC: 5931550. DOI: 10.1038/s41598-018-24878-y. View

20.

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View